Cargando…
Comment on “Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury” Cancers 2019, 11, 1687
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072697/ https://www.ncbi.nlm.nih.gov/pubmed/32028697 http://dx.doi.org/10.3390/cancers12020343 |
| _version_ | 1783506466918891520 |
|---|---|
| author | Aldinucci, Donatella Colombatti, Alfonso |
| author_facet | Aldinucci, Donatella Colombatti, Alfonso |
| author_sort | Aldinucci, Donatella |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7072697 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70726972020-03-19 Comment on “Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury” Cancers 2019, 11, 1687 Aldinucci, Donatella Colombatti, Alfonso Cancers (Basel) Comment MDPI 2020-02-03 /pmc/articles/PMC7072697/ /pubmed/32028697 http://dx.doi.org/10.3390/cancers12020343 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Comment Aldinucci, Donatella Colombatti, Alfonso Comment on “Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury” Cancers 2019, 11, 1687 |
| title | Comment on “Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury” Cancers 2019, 11, 1687 |
| title_full | Comment on “Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury” Cancers 2019, 11, 1687 |
| title_fullStr | Comment on “Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury” Cancers 2019, 11, 1687 |
| title_full_unstemmed | Comment on “Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury” Cancers 2019, 11, 1687 |
| title_short | Comment on “Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury” Cancers 2019, 11, 1687 |
| title_sort | comment on “fibroblasts in nodular sclerosing classical hodgkin lymphoma are defined by a specific phenotype and protect tumor cells from brentuximab-vedotin induced injury” cancers 2019, 11, 1687 |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072697/ https://www.ncbi.nlm.nih.gov/pubmed/32028697 http://dx.doi.org/10.3390/cancers12020343 |
| work_keys_str_mv | AT aldinuccidonatella commentonfibroblastsinnodularsclerosingclassicalhodgkinlymphomaaredefinedbyaspecificphenotypeandprotecttumorcellsfrombrentuximabvedotininducedinjurycancers2019111687 AT colombattialfonso commentonfibroblastsinnodularsclerosingclassicalhodgkinlymphomaaredefinedbyaspecificphenotypeandprotecttumorcellsfrombrentuximabvedotininducedinjurycancers2019111687 |